CENTENE CORP CNC

Centene's strongest supplied fact is the scale of its latest official quarter: SEC EDGAR filed financials show Revenues of $49.94B, Net Income Attributable to Parent of $1.54B, Operating Income of $1.86B and diluted earnings per share of $3.11 for the 10-Q period ending 2026-03-31. The same filing rail gives Cash and Cash Equivalents of $21.26B, Assets of $81.17B, Liabilities of $59.65B and Stockholders' Equity Attributable to Parent of $21.43B.

Centene is a managed care organisation, and the official issuer site describes the company as providing access to high-quality healthcare solutions for families and individuals. That matters because this equity story is not just a screen symbol. It is a contracting, service and administration business tied to healthcare access, public programmes and the practical task of delivering managed care at scale.

The latest supplied filing detail adds operating texture. The 2026-04-28 10-Q says premium and service revenues were $44.7B, representing 5% growth year-over-year. It also says SilverSummit Healthplan began the Nevada Department of Health and Human Services Medicaid managed care contract in January 2026, and Sunshine Health began the expanded Florida Statewide Medicaid Managed Care programme in February 2025, including Managed Medical Assistance, Long-Term Care services, Serious Mental Illness, Child Welfare and HIV specialty products.

No chart route, candle data or price level is supplied in this evidence pack, so the market mechanism has to be read through official sources rather than invented technical commentary. The public rail here consists of SEC EDGAR filings, SEC submissions and company source material. That keeps the report on what can be proved: earnings scale, balance sheet figures, cash generation, named healthcare programme activity and a recent run of ownership-related SEC forms.

The news rail after the quarter is mostly disclosure activity. SEC EDGAR lists Centene Form 4 filings dated 2026-06-15, 2026-06-11, 2026-06-02 and 2026-05-26, a Form 144 dated 2026-06-10, and a Form 3 dated 2026-05-18. The supplied evidence does not include the transaction lines from those forms, so the claim stops there: the filing calendar has been active, but the exact insider transaction economics are not parsed in this rail.

The evidence would deepen materially with parsed Form 4 and Form 144 transaction fields, any management guidance from the 2026-04-28 earnings release, and a live chart source if the report is meant to discuss price behaviour. Without those, the credible story is still substantial: Centene has a large first-quarter filing base, named Medicaid programme activity and a clean official-source trail, but no supplied proof for market levels, analyst sentiment or guidance change.